Contenu disponible en anglais seulement.
Examen de radiation de la TSX - Acerus Pharmaceuticals Corporation (ASP, ASP.WT)
9 mars 2020
| Issuer: |
Acerus Pharmaceuticals Corporation (the "Company") |
| Securities: |
Common shares Common share purchase warrants |
| Symbol(s): |
ASP ASP.WT |
| Delisting Review Status: |
TSX has determined that the Company has regained compliance with the requirements for continued listing. |
| Additional Information: |
Please refer to TSX Bulletin #2020-0101 dated February 13, 2020. |
| TSX contact: |
Chris Birkett, Director, Toronto Stock Exchange. |